other material
confidence high
sentiment neutral
materiality 0.60
Aclarion prices $4.7M registered direct offering of 506,803 shares at $9.25 each
Aclarion, Inc.
- Gross proceeds ~$4.7M; 506,803 shares at $9.25/share; closing expected Jan 31, 2025.
- Net proceeds to fund market development, clinical evidence, product development, and G&A.
- Dawson James Securities serving as sole placement agent; offering under effective S-3 shelf.
- Offering priced at the market; no change to previously announced business plans.